retatrutide weight loss study results obesity trial in 28 percent average Phase III retatrutide demonstrates – The weight loss on Reta

Two injectable medications we offer in our comprehensive weight loss program are Zepbound (tirzepatide) and Wegovy (semaglutide)

GLP-1 agonists have emerged as powerful adjuncts for glycemic control, weight management, and cardiovascular risk reduction in recent years, particularly in individuals with obesity or established cardiovascular disease

A promising development in both obesity and diabetes care

Rapid-acting insulins Admelog Afrezza (inhalation) Apidra Fiasp Humalog Kirsty Lyumjev Merilog NovoLog Short-acting insulin (Human insulin) Humulin R Novolin R Intermediate-acting insulin (NPH insulin) Humulin N Novolin N Long-acting insulin Lantus Basaglar Toujeo Levemir Tresiba Rezvoglar Semglee Premixed insulin Humalog Mix 50/50 Humalog Mix 75/25 Humulin 70/30 Novolin 70/30 Novolog Mix 70/30 What does insulin do to blood sugar